Home > Boards > US Listed > Biotechs > Maravai LifeSciences Holdings Inc. (MRVI)

Maravai LifeSciences Holdings, Inc. is a life sciences

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
crudeoil24 Member Profile
Member Level 
Followed By 705
Posts 47,353
Boards Moderated 5
Alias Born 12/12/04
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/13/2021 4:22:25 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 9/13/2021 4:17:19 PM
Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders GlobeNewswire Inc. - 9/10/2021 6:30:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/10/2021 6:04:59 AM
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders GlobeNewswire Inc. - 9/7/2021 4:10:42 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/7/2021 4:07:14 PM
Maravai LifeSciences Announces September 2021 Investor Conference Schedule GlobeNewswire Inc. - 9/7/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/3/2021 4:07:17 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/11/2021 4:57:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2021 4:19:00 PM
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance GlobeNewswire Inc. - 8/10/2021 4:05:00 PM
TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vaccine Research Center (Chula VRC), Bangkok GlobeNewswire Inc. - 8/2/2021 6:00:00 PM
Codex DNA up 7% on Maravai supply deal for mRNA capping technology Seeking Alpha - 7/21/2021 1:36:34 PM
Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA Capping Technology GlobeNewswire Inc. - 7/21/2021 7:07:00 AM
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, August 10, 2021 GlobeNewswire Inc. - 7/20/2021 4:15:00 PM
Maravai LifeSciences Announces June 2021 Investor Conference Schedule GlobeNewswire Inc. - 5/26/2021 4:10:00 PM
Maravai LifeSciences announces election of directors Seeking Alpha - 5/21/2021 9:19:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2021 4:13:32 PM
Maravai LifeSciences Holdings EPS beats by $0.05, beats on revenue Seeking Alpha - 5/10/2021 4:22:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2021 4:21:41 PM
Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance GlobeNewswire Inc. - 5/10/2021 4:05:00 PM
Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021 GlobeNewswire Inc. - 5/5/2021 4:10:00 PM
Biotech Veterans Troy Cox, Susannah Gray and Karen McGinnis Join Biosplice Therapeutics Board of Directors GlobeNewswire Inc. - 4/20/2021 8:45:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/19/2021 4:47:49 PM
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021 GlobeNewswire Inc. - 4/13/2021 4:15:00 PM
crudeoil24 Member Level  Wednesday, 03/03/21 08:45:10 AM
Re: None
Post # of 3 
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The Company's segments include Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its Biologics Safety Testing segment sells specialized analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Company's Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry.

New York Yankees and Duke Basketball
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences